Ads
related to: metastatic renal cell carcinoma- Clinical Trials Results
Access Clinical Trial Results
and Information Here.
- Official Patient Website
Learn About a Treatment Plan
That May Be Right for You.
- Treatment Resources
Learn About ARCC Treatment
Resources for Eligible Patients.
- Getting Started
Understanding Your Treatment Plan
May Help You Get Started.
- Clinical Trials Results
Search results
Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments
GuruFocus.com via Yahoo Finance· 4 months agoExelixis Inc. (NASDAQ:EXEL) is a pharmaceutical company headquartered in Alameda, California that...
Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain on Study Data
Zacks via Yahoo Finance· 6 months agoIt was a busy week for the biotech sector, with numerous study readouts and other updates. Quite a...
Will Keytruda & Gardasil Aid Merck (MRK) Sales in Q4 Earnings?
Zacks via Yahoo Finance· 1 year agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor, Keytruda,...
LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial
Clinical Trials Arena via Yahoo Finance· 7 days agoLG Chem and its subsidiary AVEO Oncology have announced the commencement of a Phase I clinical study...
7 Myths About Kidney Cancer, Debunked
Time via Yahoo News· 1 year agodoctor holding orange ribbon. campaign to prevent skin cancer, melanoma, December orange Credit - Leonidas Santana—Getty Images Kidney cancer may well be...
Is Kidney Cancer Curable? Understanding the Odds
Verywell Health via Yahoo News· 5 months agoThere are several types of kidney (renal) cancer. Each type is potentially curable if it's found and treated early, before the cancer has a chance to...
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
Benzinga via Yahoo Finance· 1 year agoExelixis Inc (NASDAQ: EXEL) announced that the phase 3 CONTACT-03 study did not meet its primary...
Iovance (IOVA) Posts Narrower-Than-Expected Loss in Q2
Zacks via Yahoo Finance· 10 months agoIovance Biotherapeutics, Inc. IOVA incurred a loss of 47 cents per share in second-quarter 2023,...
Exelixis (EXEL) Collaborates With Arcus for Kidney Cancer Study
Zacks via Yahoo Finance· 7 months agoExelixis, Inc. EXEL entered into a clinical collaboration with clinical-stage company Arcus...
Is Exelixis' (EXEL) Growth Story Likely to Continue?
Zacks via Yahoo Finance· 2 years agoExelixis EXEL, an oncology-focused company, maintains momentum on the back of the solid performance of its lead drug Cabometyx amid stiff competition...
Ads
related to: metastatic renal cell carcinoma